FDA Biosimilars Chief Leah Christl Joining Amgen; Agency Veteran Sarah Yim Takes Her Place

 
• By Brenda Sandburg

Christl joins Amgen's policy team in Washington, DC. Yim was reviewer for Inflectra and Amjevita biosimilars.

FDA words adn building icon

More from US FDA

More from Agency Leadership